HIF-1α Directly Controls WNT7A Expression During Myogenesis.

Area of Science:

• Molecular Biology
• Muscle Physiology
• Cellular Biology

Background:

• Hypoxia-inducible factor-1α (HIF-1α) is a key regulator of cellular response to oxygen levels.
• WNT7A plays a role in embryonic development and tissue regeneration.
• Understanding the interplay between HIF-1α and WNT7A in muscle is crucial for regenerative medicine.

Purpose of the Study:

• To investigate the direct regulatory role of HIF-1α on WNT7A expression during myogenesis.
• To explore the functional consequences of HIF-1α-mediated WNT7A regulation on muscle differentiation and regeneration.
• To evaluate the therapeutic potential of targeting the HIF-1α/WNT7A pathway in muscle injury.

Main Methods:

• Chromatin immunoprecipitation (ChiP) and site-directed mutagenesis to identify HIF-1α binding sites on the WNT7A promoter.
• Pharmacological activation of HIF-1α and CRISPR/Cas9-mediated WNT7A silencing.
• In vitro and in vivo studies using a cardiotoxin-induced muscle injury mouse model.
• Treatment with prolyl hydroxylases (PHDs) inhibitors.

Main Results:

• Identified two hypoxia response elements (HREs) on the WNT7A promoter as direct HIF-1α binding sites.
• Pharmacological HIF-1α activation upregulated WNT7A expression and promoted muscle differentiation.
• WNT7A silencing abrogated the pro-myogenic effects of HIF-1α activation.
• PHD inhibitor treatment enhanced muscle regeneration in vitro and in vivo.

Conclusions:

• HIF-1α directly controls WNT7A expression, a critical step in myogenesis.
• The HIF-1α/WNT7A axis is a key regulator of muscle differentiation and regeneration.
• PHD inhibitors represent a promising therapeutic strategy for muscle injury and pathologies.